DOCSLIB.ORG

Role of Serum Enzymes in Assessing the Efficacy of Radiation Therapy for Human Carcinoma of Uterine Cervix

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Role of Serum Enzymes in Assessing the Efficacy of Radiation Therapy for Human Carcinoma of Uterine Cervix J Clin. Biochem. Nutr., 19, 97-105, 1995 Role of Serum Enzymes in Assessing the Efficacy of Radiation Therapy for Human Carcinoma of Uterine Cervix Natarajan BALASUBRAMANIYAN,Sorimuthu SUBRAMANIAN, and Saminathan GOVINDASAMY* Departmentof Biochemistry,University of Madras, Guindy Campus, Madras-600 025, India (ReceivedMarch 29, 1995) Summary In different stages of carcinoma of the uterine cervix, the activities of serum 5'-nucleotidase, lactate dehydrogenase (LDH), phos- phohexose isomerase (PHI), ƒÁ-glutamyl transpeptidase (GGT), trans- aminases, and phosphatases were studied before and after radiation treatment. Glycolytic enzymes (LDH, PHI) were found to be increased from stage I onwards, whereas GGT, glutamate oxaloacetate trans- aminase, glutamate pyruvate transaminase, and acid and alkaline phos- phatases increased only in the advanced stages (stages III, IV), when compared with normal values. 5'-Nucleotidase was found to be increased significantly from stage II onwards when compared with the normal. The increased levels of these enzymes were reversed to near normal levels after radiotherapy. The increased levels of serum transaminases, phosphatases, and GGT in the advanced stages of carcinoma of uterine cervix may be explained on the basis of liver involvement and bone metastasis. The degree of increase in the activities of PHI and LDH may reflect the status of the cancer. The activity of 5'-nucleotidase in serum may be used as an additional marker to assess the status of carcinoma of uterine cervix under circumstances when other markers fail to provide clear indications. Key Wards: carcinoma, glycolytic enzymes, 5'-nucleotidase, trans- aminases, phosphatases The measurement of biochemical markers is being increasingly used for early diagnosis and monitoring of the progress of cancer. Derangement in the metabolic *To whom correspondence should be addressed . 97 98 N. BALASUBRAMANIYAN, S. SUBRAMANIAN, and S. GOVINDASAMY processes are often reflected in the changes of enzymatic activities. Extensive research has been conducted by numerous workers over the past few decades to find enzyme activity differences between normal and tumor cells . Many types of tumor cells secrete much larger quantities of glycolytic enzymes into the blood- stream, as a result of increased glycolytis in neoplastic cells. As a single enzyme may exhibit a similar type of changes under some non-malignant conditions, a combination of different enzyme markers is more significant and valuable than any single enzyme marker. Rao et al. [ 1 ] reported the usefulness of multiple enzyme assays in the diagnosis of various cancer cases. Phosphohexose isomerase (PHI) catalyzes the conversion of glucose-6-phos- phate to fructose-6-phosphate in the glycolytic cycle. Lactate dehydrogenase (LDH), a tetrameric enzyme composed two immunologically distinct subunits (M and H) regulates the interconversion of pyruvate and lactate, the last step of the glycolytic pathway; and this enzyme has been extensively studied and found useful in the recognition of neoplastic disease [2]. Kim et al. [3] concluded LDH activity to be a very useful marker in the diagnosis and prognosis of cancer . Roguljic et al. [4] reported a study showing that PHI, LDH, and the isoenzyme pattern of LDH in combination were very useful in distinguishing fibroadenoma from breast carcinoma. y-Glutamyl transpeptidase (GGT) is a membrane-bound glycoprotein that catalyzes the transfer of y-glutamyl groups between amino acids or peptides [5]. The physiological function of GGT is thought to be the mediation of amino acid translocation across the cell membrane [6]. Although the highest concentration of GGT is found in the brush borders of the epithelial cells that line the proximal convoluted tubules of the kidney, the enzyme has also been demonstrated in a variety of human tissues and body fluids [7]. Transaminases are an important class of enzymes linking carbohydrate and amino acid metabolism, and the study of these enzymes has established the relationships among the intermediates of the citric acid cycle. 5'-Nucleotidase is an established plasma membrane marker in many mammalian cells where the enzyme is present as an ectoenzyme [8]. Boone et al: [9] found that serum 5'-nucleotidase is almost as useful as GGT in indicating hepatobiliary disease in patients with granuloma of the liver, acute pancreatitis, congestive heart failure, rheumatoid arthritis, and carcinoma metastatic of the liver. Kim et al. [3] assessed the diagnostic value of measuring serum alkaline phosphatase, 5'-nucleotidase, GGT, and glutamate dehydrogenase activities as an aid to the detection of liver metas- tasis. Hence, in the present study we sought to correlate the activities of these enzymes in the sera of uterine cervical cancer patients with their disease status to understand their validity in diagnosis and to reassess the prognosis during the course of radiotherapy. J. Clin. Biochem. Nutr. SERUM ENZYMES IN HUMAN CARCINOMA OF UTERINE CERVIX 99 MATERIALSAND METHODS This study was conducted on patients suffering from carcinoma of the uterine cervix admitted to the Cancer Institute, Adyar, Madras, India, and the Institute of Gynecology and Obstetrics, Egmore, Madras, India. In this study, blood samples were obtained from a total number of 238 patients (30 to 60 years old) in different stages of carcinoma of the uterine cervix (stage I [group II], N=35; stage II [group III], N=70; stage III [group IV], N=115; and stage IV [group V], N=18). A total number of 125 healthy females (group I) studied were professionals and employees of different institutions without any gynecological disorders. All the patients in the present study were confirmed to have cervical cancer by cytological screening, and the stages of carcinoma were assessed by oncologists. Blood samples were also collected from groups II, III, and IV after radiation treatment. Group V patients were not included for investigation after radiation therapy as they did not respond to radiation treatment. Venous blood samples were drawn from all the subjects, and serum was separated for further analysis. The activities of glutamate oxaloacetate transaminase (SGOT) (EC. 2.6,1.6) and glutamate pyruvate trans- aminase (SGPT) (EC. 2.6.1.2) were assayed by the method of Mohur and Cook [10]. PHI (EC. 5.3.1.9) was assayed following the method of Horrocks et al [11]. The activity of serum LDH (EC. 1.1.1.27) was assayed by the method of King [12]. The activities of serum acid (EC. 3.1.3.2) and alkaline (EC. 3.1.3.1) phosphatases were assayed by the method of Moog [13] as modified by King [12]. The activity of serum GGT (EC. 2.3.2.1) was assayed according to the method of Jacobs [14]. 5'-Nucleotidase was assayed following the method of Campbell [15]. STATISTICALANALYSIS Serum LDH, PHI, GGT, SCOT, SGPT, 5'-nucleotidase, and acid and alka- line phosphatases values were expressed as the mean +SD for patients and the healthy population separately. The statistical differences were analyzed by Stu- dent's t-test, and p-value were expressed. Analysis of variance (ANOVA) was done to compare the mean levels of the parameters at different stages of carcinoma of the uterine cervix before and after radiation treatment. RESULTS The activities of serum LDH, PHI, SCOT, and SGPT, in normal and patients with carcinoma of uterine cervix before and after radiotherapy are presented in Table 1. LDH and PHI activities were found to be increased significantly (p < 0.001) in the group-II, -III, -IV, and -V patients, whereas the activities of SGOT and SGPT were increased in group-IV and -V patients only, when compared with the normal values. Group-II and -III patients showed no significant change from Vol. 19, No. 2, 1995 100 N. BALASUBRAMANIYAN, S. SUBRAMANIAN, and S. GOVINDASAMY Table 1. Activities of serum lactate dehydrogenase (LDH), phosphohexose isomerase (PHI), glutamate oxaloacetate transaminase (SCOT), and glutamate pyruvate transaminase (SGPT) in normal individuals and in patients with carcinoma of uterine cervix before and after radiotherapy. The values are expressed as IU/liter, mean±SD, with the number of individuals indicated in parentheses. p-Value: * * * <0.001, normals versus different stages of carcinoma , p-Value: +++<0 .001, before treatment versus after treatment. aSignificant difference from other groups (p<0.001). Table 2. Activities of serum acid and alkaline phosphatases, y-glutamyl transpeptidase (GGT), and 5'-nucleotidase in normal individuals and in patients with carcinoma of uterine cervix before and after radiotherapy. [be values are expressed as IU/liter, mean±SD, with the number of individuals indicated in parentheses. p-Value: * * * <0.001, normals versus different stages of carcinoma, p-Value: +++<0 .001, before treatment versus after treatment. aSignificant difference from other groups (p<0.001). normal in the level of activity of SGOT and SGPT. The activities of LDH and PHI were found to be decreased after radiation treatment from their elevated levels in stage-I, -II, and -III patients. The activities of SGOT and SGPT decreased significantly after radiation treatment in group-IV patients when compared with their pretreatment values. J. Clin. Biochem. Nutr. SERUM ENZYMES IN HUMAN CARCINOMA OF UTERINE CERVIX 101 Table 2 shows the activities of serum GGT, 5'-nucleotidase, and acid and alkaline phosphatases in normal and patients with carcinoma of uterine cervix before and after radiotherapy. The activities of GGT and acid and alkaline phosphatases were increased significantly (p<0.001) in group-IV and -V patients, but there was no significant change in their values of groups II and III when compared with normal levels. Radiotherapy resulted in the return of all these enzyme activities to near normal in group-IV patients. Radiation treatment did not produce any change in the activities of these enzymes in group-II and -III patients. The activity of 5'-nucleotidase was significantly elevated in group-III, -IV, and -V patients. After radiotherapy the enzyme activity was found to be normal in the sera of these cervical cancer patients.
Load more

Recommended publications
  • NADPH-Dependent A-Oxidation of Unsaturated Fatty Acids With
    Proc. Natl. Acad. Sci. USA Vol. 89, pp. 6673-6677, August 1992 Biochemistry NADPH-dependent a-oxidation of unsaturated fatty acids with double bonds extending from odd-numbered carbon atoms (5-enoyl-CoA/A3,A2-enoyl-CoA isomerase/A3',52'4-dienoyl-CoA isomerase/2,4-dienoyl-CoA reductase) TOR E. SMELAND*, MOHAMED NADA*, DEAN CUEBASt, AND HORST SCHULZ* *Department of Chemistry, City College of the City University of New York, New York, NY 10031; and tJoined Departments of Chemistry, Manhattan College/College of Mount Saint Vincent, Riverdale, NY 10471 Communicated by Salih J. Wakil, April 13, 1992 ABSTRACT The mitochondrial metabolism of 5-enoyl- a recent observation of Tserng and Jin (5) who reported that CoAs, which are formed during the (3-oxidation of unsaturated the mitochondrial -oxidation of 5-enoyl-CoAs is dependent fatty acids with double bonds extending from odd-numbered on NADPH. Their analysis of metabolites by gas chroma- carbon atoms, was studied with mitochondrial extracts and tography/mass spectrometry led them to propose that the purified enzymes of (3-oxidation. Metabolites were identified double bond of 5-enoyl-CoAs is reduced by NADPH to yield spectrophotometrically and by high performance liquid chro- the corresponding saturated fatty acyl-CoAs, which are then matography. 5-cis-Octenoyl-CoA, a putative metabolite of further degraded by P-oxidation. linolenic acid, was efficiently dehydrogenated by medium- This report addresses the question of how 5-enoyl-CoAs chain acyl-CoA dehydrogenase (EC 1.3.99.3) to 2-trans-5-cis- are chain-shortened by P-oxidation. We demonstrate that octadienoyl-CoA, which was isomerized to 3,5-octadienoyl- 5-enoyl-CoAs, after dehydrogenation to 2,5-dienoyl-CoAs, CoA either by mitochondrial A3,A2-enoyl-CoA isomerase (EC can be isomerized to 2,4-dienoyl-CoAs, which are reduced by 5.3.3.8) or by peroxisomal trifunctional enzyme.
    [Show full text]
  • Regulation of the Tyrosine Kinase Itk by the Peptidyl-Prolyl Isomerase Cyclophilin A
    Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A Kristine N. Brazin, Robert J. Mallis, D. Bruce Fulton, and Amy H. Andreotti* Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA 50011 Edited by Owen N. Witte, University of California, Los Angeles, CA, and approved December 14, 2001 (received for review October 5, 2001) Interleukin-2 tyrosine kinase (Itk) is a nonreceptor protein tyrosine ulation of the cis and trans conformers. The majority of folded kinase of the Tec family that participates in the intracellular proteins for which three-dimensional structural information has signaling events leading to T cell activation. Tec family members been gathered contain trans prolyl imide bonds. The cis con- contain the conserved SH3, SH2, and catalytic domains common to formation occurs at a frequency of Ϸ6% in folded proteins (17), many kinase families, but they are distinguished by unique se- and a small subset of proteins are conformationally heteroge- quences outside of this region. The mechanism by which Itk and neous with respect to cis͞trans isomerization (18–21). Further- related Tec kinases are regulated is not well understood. Our more, the activation energy for interconversion between cis and studies indicate that Itk catalytic activity is inhibited by the peptidyl trans proline is high (Ϸ20 kcal͞mol) leading to slow intercon- prolyl isomerase activity of cyclophilin A (CypA). NMR structural version rates (22). This barrier is a rate-limiting step in protein studies combined with mutational analysis show that a proline- folding and may serve to kinetically isolate two functionally and dependent conformational switch within the Itk SH2 domain reg- conformationally distinct molecules.
    [Show full text]
  • Phosphoglucose Isomerase (Pgi)
    NIPRO ENZYMES PHOSPHOGLUCOSE ISOMERASE (PGI) [EC 5. 3. 1. 9] from Bacillus stearothermophilus D-Glucose 6-phosphate ↔ D-Fructose 6-phosphate SPECIFICATION State : Lyophilized Specific activity : more than 400 U/mg protein Contaminants : (as PGI activity = 100 %) Phosphofructokinase < 0.01 % 6-Phosphogluconate dehydrogenase < 0.01 % Phosphoglucomutase < 0.01 % NADPH oxidase < 0.01 % Glutathione reductase < 0.01 % PROPERTIES Molecular weight : ca. 200,000 Subunit molecular weight : ca. 54,000 Optimum pH : 9.0 - 10.0 (Fig. 1) pH stability : 6.0 - 10.5 (Fig. 2) Isoelectric point : 4.2 Thermal stability : No detectable decrease in activity up to 60 °C. (Fig. 3, 4) Michaelis constants : (95mM Tris-HCI buffer, pH 9.0, at 30 °C) Fructose 6-phospate 0.27 mM STORAGE Stable at -20 °C for at least one year NIPRO ENZYMES ASSAY Principle The change in absorbance is measured at 340nm according to the following reactions. Fructose 6-phosphate PGI Glucose 6-phosphate + G6PDH + Glucose 6-phosphate + NADP Gluconolactone 6-phosphate + NADPH + H Unit Definition One unit of activity is defined as the amount of PGI that forms 1 μmol of glucose 6-phosphate per minute at 30 °C. Solutions Ⅰ Buffer solution ; 100 mM Tris-HCl, pH 9.0 Ⅱ Fructose 6-phosphate (F6P) solution ; 100 mM (0.310 g F6P disodium salt/10 mL distilled water) + + Ⅲ NADP solution ; 22.5 mM (0.188 g NADP sodium salt∙4H2O/10 mL distilled water) Ⅳ Glucose-6-phosphate dehydrogenase (G6PDH) ; (from yeast, Roche Diagnostics K.K., No. 127 671) suspension in 3.2 M (NH4)2SO4 solution (10 mg/2 mL) approx.
    [Show full text]
  • Inhibitor for Protein Disulfide‑Isomerase Family a Member 3
    ONCOLOGY LETTERS 21: 28, 2021 Inhibitor for protein disulfide‑isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16 YOHEI KANEYA1,2, HIDEYUKI TAKATA2, RYUICHI WADA1,3, SHOKO KURE1,3, KOUSUKE ISHINO1, MITSUHIRO KUDO1, RYOTA KONDO2, NOBUHIKO TANIAI4, RYUJI OHASHI1,3, HIROSHI YOSHIDA2 and ZENYA NAITO1,3 Departments of 1Integrated Diagnostic Pathology, and 2Gastrointestinal and Hepato‑Biliary‑Pancreatic Surgery, Nippon Medical School; 3Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo 113‑8602; 4Department of Gastrointestinal and Hepato‑Biliary‑Pancreatic Surgery, Nippon Medical School Musashi Kosugi Hospital, Tokyo 211‑8533, Japan Received April 16, 2020; Accepted October 28, 2020 DOI: 10.3892/ol.2020.12289 Abstract. mTOR is involved in the proliferation of liver 90.2±10.8% by 16F16 but to 62.3±12.2% by combination treat‑ cancer. However, the clinical benefit of treatment with mTOR ment with Ev and 16F16. HuH‑6 cells were resistant to Ev, and inhibitors for liver cancer is controversial. Protein disulfide proliferation was reduced to 86.7±6.1% by Ev and 86.6±4.8% isomerase A member 3 (PDIA3) is a chaperone protein, and by 16F16. However, combination treatment suppressed prolif‑ it supports the assembly of mTOR complex 1 (mTORC1) and eration to 57.7±4.0%. Phosphorylation of S6K was reduced by stabilizes signaling. Inhibition of PDIA3 function by a small Ev in both Li‑7 and HuH‑6 cells. Phosphorylation of 4E‑BP1 molecule known as 16F16 may destabilize mTORC1 and was reduced by combination treatment in both Li‑7 and HuH‑6 enhance the effect of the mTOR inhibitor everolimus (Ev).
    [Show full text]
  • Deamidated Human Triosephosphate Isomerase Is a Promising Druggable Target
    biomolecules Article Deamidated Human Triosephosphate Isomerase Is a Promising Druggable Target Sergio Enríquez-Flores 1,*, Luis Antonio Flores-López 1,2, Itzhel García-Torres 1, Ignacio de la Mora-de la Mora 1 , Nallely Cabrera 3, Pedro Gutiérrez-Castrellón 4 , Yoalli Martínez-Pérez 5 and Gabriel López-Velázquez 1,* 1 Grupo de Investigación en Biomoléculas y Salud Infantil, Laboratorio de EIMyT, Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico; [email protected] (L.A.F.-L.); [email protected] (I.G.-T.); [email protected] (I.d.l.M.-d.l.M.) 2 CONACYT-Instituto Nacional de Pediatría, Secretaría de Salud, Mexico City 04530, Mexico 3 Departamento de Bioquímica y Biología Estructural, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico; [email protected] 4 Hospital General Dr. Manuel Gea González, Mexico City 14080, Mexico; [email protected] 5 Unidad de Investigación en Medicina Experimental, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico; [email protected] * Correspondence: [email protected] (S.E.-F.); [email protected] (G.L.-V.); Tel.: +52-55-10840900 (G.L.-V.) Received: 9 June 2020; Accepted: 10 July 2020; Published: 15 July 2020 Abstract: Therapeutic strategies for the treatment of any severe disease are based on the discovery and validation of druggable targets. The human genome encodes only 600–1500 targets for small-molecule drugs, but posttranslational modifications lead to a considerably larger druggable proteome. The spontaneous conversion of asparagine (Asn) residues to aspartic acid or isoaspartic acid is a frequent modification in proteins as part of the process called deamidation.
    [Show full text]
  • Protein Disulfide-Isomerase A3 Significantly Reduces Ischemia
    Neurochemistry International 122 (2019) 19–30 Contents lists available at ScienceDirect Neurochemistry International journal homepage: www.elsevier.com/locate/neuint Protein disulfide-isomerase A3 significantly reduces ischemia-induced damage by reducing oxidative and endoplasmic reticulum stress T Dae Young Yooa,b,1, Su Bin Choc,1, Hyo Young Junga, Woosuk Kima, Kwon Young Leed, Jong Whi Kima, Seung Myung Moone,f, Moo-Ho Wong, Jung Hoon Choid, Yeo Sung Yoona, ∗ ∗∗ Dae Won Kimh, Soo Young Choic, , In Koo Hwanga, a Department of Anatomy and Cell Biology, College of Veterinary Medicine, Research Institute for Veterinary Science, Seoul National University, Seoul, 08826, South Korea b Department of Anatomy, College of Medicine, Soonchunhyang University, Cheonan, Chungcheongnam, 31151, South Korea c Department of Biomedical Sciences, Research Institute for Bioscience and Biotechnology, Hallym University, Chuncheon, 24252, South Korea d Department of Anatomy, College of Veterinary Medicine and Institute of Veterinary Science, Kangwon National University, Chuncheon, 24341, South Korea e Department of Neurosurgery, Dongtan Sacred Heart Hospital, College of Medicine, Hallym University, Hwaseong, 18450, South Korea f Research Institute for Complementary & Alternative Medicine, Hallym University, Chuncheon, 24253, South Korea g Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, 24341, South Korea h Department of Biochemistry and Molecular Biology, Research Institute of Oral Sciences, College of Dentistry, Gangneung-Wonju
    [Show full text]
  • Scaffoldless Engineered Enzyme Assembly for Enhanced Methanol Utilization
    Scaffoldless engineered enzyme assembly for enhanced methanol utilization J. Vincent Pricea, Long Chena, W. Brian Whitakera,b, Eleftherios Papoutsakisa,b, and Wilfred Chena,1 aDepartment of Chemical and Biomolecular Engineering, University of Delaware, Newark, DE 19716; and bThe Delaware Biotechnology Institute, University of Delaware, Newark, DE 19711 Edited by Arnold L. Demain, Drew University, Madison, NJ, and approved September 27, 2016 (received for review February 4, 2016) Methanol is an important feedstock derived from natural gas and organisms requires electrons in the form of NADH and culture can be chemically converted into commodity and specialty chem- conditions largely microaerobic or anaerobic (7, 10). Thus, or- icals at high pressure and temperature. Although biological ganisms that can grow anaerobically or microaerobically and NAD- conversion of methanol can proceed at ambient conditions, there dependent Mdhs are essential for effective conversion of methanol + is a dearth of engineered microorganisms that use methanol to to desirable metabolites (7). Although NAD(P) -dependent Mdhs produce metabolites. In nature, methanol dehydrogenase (Mdh), are the best candidates for engineering synthetic methylotrophs which converts methanol to formaldehyde, highly favors the reverse like Escherichia coli, these enzymes have poor predicted thermo- reaction. Thus, efficient coupling with the irreversible sequestration dynamic properties and are thus dependent on maintaining low of formaldehyde by 3-hexulose-6-phosphate synthase (Hps)
    [Show full text]
  • Y-Glutamyltransferase in Putative Premalignant Liver Cell Populations During Hepatocarcinogenesis1
    [CANCER RESEARCH 38, 823-829, March 1978] y-Glutamyltransferase in Putative Premalignant Liver Cell Populations During Hepatocarcinogenesis1 Ross Cameron,2 John Kellen, Arnost Kolin, Aaron Malkin, and Emmanuel Farber Department of Pathology. University of Toronto. Toronto U5G 1L5 ¡R.C., A. K., E. F.], and Department of Clinical Biochemistry, Sunnybrook Medical Centre, Toronto M4N 3U5 [J. K., A. M.¡,Ontario Canada ABSTRACT the fetus but very low activity in the adult. In primary tumors induced by aflatoxin B,, 3'-Me-DAB, N-OH-2-AAF, and 2- The activity of y-glutamyltransferase, as measured AAF and in transplantable hepatomas of rats, a 30- to 50- quantitatively and by histochemical staining, was studied fold increase in GGT activity has been observed (8, 9, 11, in different cell populations during the induction of liver 34). GGT activity of whole liver showed a 5-fold increase as cancer with 2-acetylaminofluorene (2-AAF) or diethylni- early as 4 weeks after 2-AAF treatment, by 6 weeks after 3'- trosamine and compared with findings in fetal and in Me-DAB, and by 8 weeks after N-OH-2-AAF (9, 11). Since intact and regenerating adult liver. The enzyme activity is duct epithelial cells show the highest concentration of GGT 20-fold higher in 12-week nodules than in control livers in normal liver as judged by histochemistry and since and 30-fold higher in 20-week nodules than in controls. A proliferation of these cells ("oval cells"), often to striking similar 30-fold increase in activity relative to control is degrees, is a common reaction in the liver during carcino- present in hepatomas, induced by either 2-AAF or dieth- genesis with many chemicals, the interpretation of the ylnitrosamine, and in fetal hepatocytes.
    [Show full text]
  • Properties of D-Xylose Isomerase from Streptomyces Albus SERGIO SANCHEZ' and KARL L
    APPLin MICoOBIOLGY, June 1975, p. 745-750 Vol. 29, No. 6 Copyright 0 1975 American Society for Microbiology Printed in U.S.A. Properties of D-Xylose Isomerase from Streptomyces albus SERGIO SANCHEZ' AND KARL L. SMILEY* Northern Regional Research Laboratory, Agricultural Research Service, U.S. Department of Agriculture, Peoria, Illinois 61604 Received for publication 6 January 1975 A partially purified D-xylose isomerase has been isolated from cells of Streptomyces albus NRRL 5778 and some of its properties have been deter- mined. D-Glucose, D-xylose, D-ribose, L-arabinose, and L-rhamnose served as substrates for the enzyme with respective Km values of 86, 93, 350, 153, and 312 mM and Vmax values measuring 1.23, 2.9, 2.63, 0.153, and 0.048 tmol/min per mg of protein. The hexose D-allose was also isomerized. The enzyme was strongly activated by 1.0 mM Mg2+ but only partially activated by 1.0 mM Co2+. The respective Km values for Mg2+ and Co2+ were 0.3 and 0.003 mM. Mg2+ and Co2+ appear to have separate binding sites on the isomerase. These cations also protect the enzyme from thermal denaturation and from D-sorbitol inhibition. The optimum temperature for ketose formation was 70 to 80 C at pH values ranging from 7 to 9. D-Sorbitol acts as a competitive inhibitor with a Ki of 5.5 mM against D-glucose, D-xylose, and D-ribose. Induction experiments, Mg2+ activation, and D-sorbitol inhibition indicated that a single enzyme (D-xylose isomerase) was responsible for the isomerization of the pentoses, methyl pentose, and glucose.
    [Show full text]
  • Variants of Phosphohexose Isomerase in Gastrointestinal And
    [CANCER RESEARCH 48. 2998-3001, June, 1988] Variants of Phosphohexose Isomerase in Gastrointestinal and Mammary Carcinoma: Isoelectric Focusing Patterns of Normal and Tumor Tissues Derived from Surgical Specimens of the Same Patient1 Matthias Baumann, Damián Jezussek, Ralf-Torsten Richter, and Karl Brand2 Institute of Biochemistry, Medical Faculty, University of Erlangen-Nuremberg, Federal Republic of Germany ABSTRACT H2PO4 H2O, 5; MgSO4 7H2O,0.77; Krebs saline buffer: H2O, 1:4; pH 7.5). The occurrence of charge variants of phosphohexose isómeras? was Then the homogenate was sonicated by 6 pulses of 10 s each at 50 elucidated in cancerous and, for comparison, in noncancerous tissues W with cooling intervals of 1 min to make sure that the temperature of the preparation remained below 10'C. Subsequently, the extract was obtained from the same organ. Surgical specimens from 35 patients with gastrointestinal and mammary carcinoma were studied by means of the rehomogenized and centrifuged at 12,000 x g for 10 min. The super isoelectric focusing (IEF) technique. Differences in the IEF pattern could natant was dialyzed against 1% glycine buffer, pH 7.5, overnight at 4'C. LKB Multiplier 2117, LKB Power Supply Unit 2103, and Servalyt be demonstrated in 90% of the patients with gastric cancer. Correspond ing values for the patients with colorectal and mammary carcinoma were Precotes, pH 3-10, were used for the isoelectric focusing experiments. 50 and 73%, respectively. Almost all normal specimens proved to be A Julabo Paratherm FT20p electronic thermostat served to cool the plate to 4'C during the run. monomorphic, revealing only the major basic band with a pi of 9.1.
    [Show full text]
  • Phosphoglucose Isomerase1 (Ec 5.3.1.9)
    Enzymatic Assay of PHOSPHOGLUCOSE ISOMERASE1 (EC 5.3.1.9) PRINCIPLE: D-Fructose 6-Phosphate PGI> D-Glucose 6-Phosphate D-Glucose 6-Phosphate + ß-NADP G-6-PDH> 6-Phosphogluconate + ß-NADPH Abbreviations used: PGI = Phosphoglucose Isomerase ß-NADPH = ß-Nicotinamide Adenine Dinucleotide Phosphate, Reduced Form ß-NADP = ß-Nicotinamide Adenine Dinucleotide Phosphate, Oxidized Form G-6-PDH = Glucose-6-Phosphate Dehydrogenase CONDITIONS: T = 25°C, pH = 7.4, A340nm, Light path = 1 cm METHOD: Continuous Spectrophotometric Rate Determination REAGENTS: A. 250 mM Glycylglycine Buffer, pH 7.4 at 25° (Prepare 100 ml in deionized water using Glycylglycine, Free Base, Sigma Prod. No. G-1002. Adjust the pH to 7.4 with 1 M NaOH.) B. 100 mM D-Fructose 6-Phosphate Solution (F-6-P) (Prepare 1 ml in deionized water using D-Fructose 6-Phosphate, Disodium, Sigma Prod. No. F-3627.) C. 20 mM ß-Nicotinamide Adenine Dinucleotide Phosphate Solution (NADP) (Prepare 1 ml in deionized water using ß-Nicotinamide Adenine Dinucleotide Phosphate, Sodium Salt, Sigma Prod. No. N-0505. PREPARE FRESH.) D. 100 mM Magnesium Chloride Solution (MgCl2) (Prepare 10 ml in deionized water using Magnesium Chloride, Hexahydrate, Sigma Prod. No. M-0250.) Revised: 01/12/94 Page 1 of 4 Enzymatic Assay of PHOSPHOGLUCOSE ISOMERASE1 (EC 5.3.1.9) REAGENTS: (continued) E. Glucose-6-Phosphate Dehydrogenase Enzyme Solution (G-6-PDH) (Immediately before use, prepare a solution containing 50 units/ml of Glucose-6-Phosphate Dehydrogenase, Sigma Prod. No. G-6378, in cold deionized water.) F. Phosphoglucose Isomerase Enzyme Solution (PGI) (Immediately before use, prepare a solution containing 0.3 - 0.7 unit/ml in cold deionized water.) PROCEDURE: Pipette (in milliliters) the following reagents into suitable cuvettes: Test Blank Deionized Water 2.00 2.00 Reagent A (Buffer) 0.50 0.50 Reagent B (F-6-P) 0.10 0.10 Reagent C (NADP) 0.10 0.10 Reagent D (MgCl2) 0.10 0.10 Reagent E (G-6-PDH) 0.10 0.10 Mix by inversion and equilibrate to 25°C.
    [Show full text]
  • Triosephosphate Isomerase from Rabbit Muscle
    Triosephosphate Isomerase from rabbit muscle Catalog Number T2391 Storage Temperature 2–8 °C CAS RN 9023-78-3 This product is purified from rabbit muscle and is EC 5.3.1.1 supplied as a suspension in 3.2 M (NH4)2SO4, pH 6.0. Synonyms: TPI; D-Glyceraldehyde-3-phosphate ketolisomerase Specific Activity: ³4,000 units/mg protein Product Description Unit Definition: One unit will convert 1.0 mmole of Triosephosphate Isomerase (TPI) catalyzes the D-glyceraldehyde-3-phosphate to dihydroxyacetone interconversion of D-glyceraldehyde 3-phosphate (GAP) phosphate per minute at pH 7.6 at 25 °C. and dihydroxyacetone phosphate (DHAP). TPI plays a role in the glycolytic pathway and in gluconeogenesis. TPI is assayed spectrophotometrically in a 3.0 ml While the reaction is reversible, the formation of reaction mixture containing 0.5 mM Tris, pH 7.6, dihydroxyacetone phosphate is favored by a ratio of 1 280 mM triethanolamine, 0.132 mM b-NADH, 4.9 mM 20:1 over the reverse reaction. DL-glyceraldehyde 3-phosphate, 4 units of a-glycerophosphate dehydrogenase, and A deficiency in TPI is an autosomal recessive disorder 0.02–0.04 unit of triosephosphate isomerase. in children under five characterized by cardiomyopathy, congenital hemolytic anemia, and susceptibility to This product contains no detectable activity for the bacterial infection. Most children with this disorder do 1 following enzymes (detection limit: % of TPI activity): not survive beyond age five. 3-phosphoglyceric phosphokinase (0.01%) pyruvate kinase (0.001%) Molecular mass: 53.2 kDa (calculated) lactic dehydrogenase (0.001%) TPI is a homodimeric protein with two 25 kDa 2,3 phosphoglucose isomerase (0.001%) subunits.
    [Show full text]